(Total Views: 363)
Posted On: 12/22/2020 1:05:49 PM
Post# of 219

$SYN News Article - Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) Phase 1b/2a Clinical Protocol https://marketwirenews.com/news-releases/synt...70584.html


My Twitter: WhyteStocks